AU2001287269A1 - Human genes and expression products - Google Patents

Human genes and expression products

Info

Publication number
AU2001287269A1
AU2001287269A1 AU2001287269A AU8726901A AU2001287269A1 AU 2001287269 A1 AU2001287269 A1 AU 2001287269A1 AU 2001287269 A AU2001287269 A AU 2001287269A AU 8726901 A AU8726901 A AU 8726901A AU 2001287269 A1 AU2001287269 A1 AU 2001287269A1
Authority
AU
Australia
Prior art keywords
expression products
human genes
genes
human
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001287269A
Other languages
English (en)
Inventor
Radomir Crkvenjakov
Mark Dickson
Radoje Drmanac
Snezana Drmanac
Jaime Escobedo
Pablo Dominguez Garcia
Veronica Garcia
Zhijun He
Michael A. Innis
Lee William Jones
Atlaf Kassam
Giulia C. Kennedy
David Kita
Ivan Labat
George Lamson
Dena Leshkowitz
David Pot
Filippo Randazzo
Christoph Reinhard
Birgit Stache-Crain
Julie Sudduth-Klinger
Lewis T. Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Hyseq Inc
Original Assignee
Hyseq Inc
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc, Chiron Corp filed Critical Hyseq Inc
Publication of AU2001287269A1 publication Critical patent/AU2001287269A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001287269A 2000-03-28 2001-03-27 Human genes and expression products Abandoned AU2001287269A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19258300P 2000-03-28 2000-03-28
US60/192,583 2000-03-28
PCT/US2001/009952 WO2001072781A2 (fr) 2000-03-28 2001-03-27 Genes humains et produits d'expression genique xvi

Publications (1)

Publication Number Publication Date
AU2001287269A1 true AU2001287269A1 (en) 2001-10-08

Family

ID=22710274

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001287269A Abandoned AU2001287269A1 (en) 2000-03-28 2001-03-27 Human genes and expression products

Country Status (5)

Country Link
US (1) US20040086913A1 (fr)
EP (1) EP1268528A2 (fr)
JP (1) JP2003528630A (fr)
AU (1) AU2001287269A1 (fr)
WO (1) WO2001072781A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050124800A1 (en) * 2002-01-23 2005-06-09 Lindsey Suzanne J. Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells
EP1340818A1 (fr) 2002-02-27 2003-09-03 Epigenomics AG Procédés et acides nucléiques pour l'analyse d'un trouble associé à la prolifération de cellules du colon
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
EP1678325A2 (fr) * 2003-09-30 2006-07-12 Chiron Corporation Nouveaux variants d'epissage du gene dkkl1 humain
ATE488587T1 (de) * 2005-12-06 2010-12-15 Ambion Inc Rückübertragungs-primer und verfahren zu deren entwurf
CN113248586B (zh) * 2021-04-23 2022-08-30 武汉大学 褐飞虱pib14蛋白及其编码基因在调控植物抗褐飞虱中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218529B1 (en) * 1995-07-31 2001-04-17 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
JP2002500010A (ja) * 1997-12-23 2002-01-08 カイロン コーポレイション ヒト遺伝子および遺伝子発現産物ｉ
US6476207B1 (en) * 1998-06-11 2002-11-05 Chiron Corporation Genes and gene expression products that are differentially regulated in prostate cancer

Also Published As

Publication number Publication date
US20040086913A1 (en) 2004-05-06
JP2003528630A (ja) 2003-09-30
WO2001072781A3 (fr) 2002-04-04
WO2001072781A9 (fr) 2003-03-06
EP1268528A2 (fr) 2003-01-02
WO2001072781A2 (fr) 2001-10-04

Similar Documents

Publication Publication Date Title
AU2001285047A1 (en) Human genes and gene expression products
AU2001245619A1 (en) Human genes and gene expression products
AU6069300A (en) Novel human genes and gene expression products
AU2001249125A1 (en) Human fgf-23 gene and gene expression products
AU4053699A (en) Novel human genes and gene expression products
AU4187499A (en) Human genes and gene expression products v
AU2095599A (en) Human genes and gene expression products i
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001245535A1 (en) Human fgf-23 gene and gene expression products
AU4117000A (en) Cosmetic product and its use
AU2002365077A1 (en) Methods and products related to non-viral transfection
AU7748200A (en) Hypoxia-related human genes, proteins, and uses thereof
AU4329300A (en) Human mesenchymal dnas and expression products
AU2001282288A1 (en) Kaolin products and their use
AU1101901A (en) Human fgf-20 gene and gene expression products
AU7924200A (en) Tooth whitening products and procedures
AU2001226922A1 (en) Cancer associated genes and their products
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2001265026A1 (en) Oilseed extract products and uses
AU2002227925A1 (en) Human beta-defensin-3
AU2001287269A1 (en) Human genes and expression products
AU2002229113A1 (en) Glucose transport-related genes and uses thereof
AU6263999A (en) Human genes and gene expression products
AU2002217984A1 (en) Erythropoietin and erythropoietin receptor expression in human cancer
AU2002243300A1 (en) Human genes and gene expression products isolated from human prostate